Pitt team finds commonly used seizure drug could treat severe genetic liver disease
Pitt team finds commonly used seizure drug could treat severe genetic liver disease
( University of Pittsburgh Schools of the Health Sciences ) The liver scarring of α1-antitrypsin (AT) deficiency, the most common genetic cause for which children undergo liver transplantation, might be reversed or prevented with a medication long used to treat seizures, according to researchers at Children’s Hospital of UPMC and the University of Pittsburgh School of Medicine. Because the anti …
Read more on EurekAlert!
Related posts:
- Use of Informatics, EMRs Enable Genetic Study of Vascular Disease
- UF researchers suggest cholera vaccination strategies for Zimbabwe
- Exome sequencing leads to correct diagnosis and life-saving treatment for mysterious genetic disorder
- Black Children at Lower Risk of Shingles after Chickenpox Vaccine; Genetic Explanation Is Most Likely, Researchers Think
- Severe form of influenza can be treated more effectively